Jazz Pharmaceuticals Plc (JAZZ)
183.59
-5.10
(-2.70%)
USD |
NASDAQ |
Mar 05, 15:17
Jazz Pharmaceuticals Cash from Investing (Quarterly) : -372.16M for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Alkermes Plc | 322.35M |
| Amarin Corp. Plc | -- |
| Medtronic Plc | -816.00M |
| Perrigo Co. Plc | -24.50M |
| STERIS Plc (Ireland) | -98.50M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 362.52M |
| Cash from Financing (Quarterly) | 75.44M |
| Free Cash Flow | 1.189B |
| Free Cash Flow Per Share (Quarterly) | 4.608 |
| Free Cash Flow to Equity (Quarterly) | 293.51M |
| Free Cash Flow to Firm (Quarterly) | 356.53M |
| Free Cash Flow Yield | 10.47% |